Section Arrow
KYNB.NASDAQ
- Kyntra Bio Inc
Quotes are at least 15-min delayed:2026/03/05 08:32 EST
Pre Market
Last
 6.71
-0.25 (-3.59%)
Bid
6.9
Ask
8
High 6.71 
Low 6.71 
Volume 31 
Regular Hours (Closed)
Last
 6.92
+0.08 (+1.17%)
Day High 
7.01 
Prev. Close
6.84 
1-M High
8.99 
Volume 
21.19K 
Bid
6.9
Ask
8
Day Low
6.82 
Open
6.88 
1-M Low
6.72 
Market Cap 
27.67M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 7.43 
20-SMA 7.6 
50-SMA 8.32 
52-W High 12.6 
52-W Low 4.85 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
53.33/-6.66
Enterprise Value
100.76M
Balance Sheet
Book Value Per Share
-4.21
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
29.62M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
KLTOKlotho Neurosciences Inc0.4126-0.1304-24.01%-- 
Pre Market 0.425 +0.0124 +3.01%
IBOImpact BioMedical Inc.0.4133+0.0033+0.80%-- 
Pre Market 0.7578 +0.3445 +83.35%
CANFCan-Fite Biopharma Ltd6.02+1.02+20.40%-- 
Pre Market 5 -1.02 -16.94%
IBRXImmunityBio9-1.005-10.04%-- 
Pre Market 9.0935 +0.0935 +1.04%
QNCXQuince Therapeutics0.104+0.007+7.22%-- 
Pre Market 0.1214 +0.0174 +16.73%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.